傳染性法氏囊病疫苗市場規模、佔有率和成長分析：按疫苗類型、給藥途徑、最終用戶、地區和產業預測，2026-2033年

2024年全球傳染性法氏囊病疫苗市值為2.9億美元，預計將從2025年的3.1349億美元成長到2033年的5.8456億美元。預測期（2026-2033年）的複合年成長率預計為8.1%。

全球傳染性法氏囊病疫苗市場的主要驅動力是家禽生產的成長和全球化。這主要是由於養殖密度增加和國際貿易導致疾病傳播風險上升和經濟脆弱性加劇。市場正在滿足對抗高傳染性病毒感染疾病的疫苗需求，這些病毒感染會威脅幼雞的免疫力並造成重大生產損失。隨著生產者將生物安全和家禽群健康放在首位，對重組疫苗和載體疫苗等技術先進的疫苗製劑的需求日益成長。分子診斷技術的創新能夠早期檢測變異株，而人工智慧 (AI) 透過整合供應鏈數據和即時資訊來增強需求預測。家禽一體化公司和生物技術公司之間的監管協調與合作正在為客製化疫苗解決方案鋪平道路，並進一步擴大市場機會。

全球傳染性法氏囊病疫苗市場促進因素

隨著家禽養殖業的快速擴張，養殖規模和密集程度日益提高，全球傳染性法氏囊病疫苗市場也隨之成長。這種情況增加了疫情爆發的風險，促使養殖戶和綜合家禽企業採取疫苗接種策略。由於生產者將動物健康放在首位，以提高生產力和產品質量，對有效疫苗的需求不斷成長，迫使生產商擴大供應並創新客製化疫苗配方。不斷成長的生產需求與預防性健康措施之間的這種協同作用，不僅使疫苗接種成為一種標準的農業實踐，而且還推動了對分銷網路和教育舉措的投資，從而促進了市場擴張。

全球傳染性法氏囊病疫苗市場的限制因素

由於儲存和處理要求必須嚴格控制溫度，全球傳染性法氏囊病疫苗市場面臨許多限制因素。這些要求使分銷變得複雜，尤其是在偏遠和資源匱乏地區，加劇了物流挑戰。對可靠低溫運輸基礎設施的依賴給供應商帶來了沉重的營運負擔，可能因擔心便利性和產品劣化風險而阻礙小規模生產者進行疫苗接種。這些分銷障礙限制了地域覆蓋範圍，使供應鏈管理複雜化，並使得製造商難以在不進行大量運輸和儲存解決方案投資的情況下，確保疫苗在各種農業系統中的一致部署，從而阻礙了市場成長。

全球傳染性法氏囊病疫苗市場趨勢

全球傳染性法氏囊病（法氏囊病）疫苗市場正經歷著向重組技術和新型疫苗平台的顯著轉變，這些技術和平台正成為產業創新的核心。製造商之所以關注這些先進技術，是因為它們具有更高的安全性、可自訂的免疫反應和高效的生產流程。這些平台能夠開發抗原特異性製劑，並有助於與疾病監測策略相結合，使其在應對病毒株不斷演變帶來的挑戰方面更具靈活性。因此，市場對既能相容於現代生產實踐又能確保對不同家禽群體具有穩定療效的疫苗的需求日益成長，這促使企業加大對可擴展生產系統的投資，並加強生物技術公司和動物用藥品公司之間的合作。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢
• 價值鏈分析

全球傳染性法氏囊病疫苗市場規模：依疫苗類型和複合年成長率分類（2026-2033 年）

• 減毒活病毒疫苗
  • 單股
  • 多價
• 去活化疫苗
  • 油膩的
  • 水溶性

全球傳染性法氏囊病疫苗市場規模：依給藥途徑及複合年成長率分類（2026-2033 年）

• 注射藥物
  • 肌肉內注射
  • 皮下注射
• 口服
  • 液體
  • 片劑配方

全球傳染性法氏囊病疫苗市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 家禽養殖場
  • 商業農場
  • 小規模家禽養殖場
• 研究機構
  • 獸醫醫學調查
  • 農業調查
• 其他

全球傳染性法氏囊病疫苗市場規模：按地區和複合年成長率分類（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco
• Cegelec
• Hipra
• Intervet
• Vetoquinol
• Virbac
• Dechra Pharmaceuticals
• Neovia
• Bioveta
• Axiota Animal Health
• Biopharma
• HyGentec
• Liaoning Hile Biotechnology
• Jinsha River Holdings
• Chengdu Tiantai Technology
• Indivior
• Sihuan Pharmaceutical

結論與建議

Global Infectious Bursal Disease Vaccine Market size was valued at USD 290.0 Million in 2024 and is poised to grow from USD 313.49 Million in 2025 to USD 584.56 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global Infectious Bursal Disease Vaccine market is primarily driven by the growth and globalization of poultry production, which heightens risks of disease transmission and economic vulnerability due to increased flock density and international trade. This market caters to the need for vaccines that combat a highly contagious viral infection that threatens the immune competence of young chickens, leading to significant production losses. As producers prioritize biosecurity and flock health, there is a growing preference for technologically advanced vaccine formulations, such as recombinant and vectored products. Innovations in molecular diagnostics enable early detection of variant strains, while AI enhances demand forecasting by integrating supply chain data and real-time insights. Regulatory alignment and collaborations between poultry integrators and biotech firms further open avenues for tailored vaccine solutions and expanded market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Bursal Disease Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Bursal Disease Vaccine Market Segments Analysis

Global infectious bursal disease vaccine market is segmented by vaccine type, administration route, end user and region. Based on vaccine type, the market is segmented into Live Attenuated Vaccine and Inactivated Vaccine. Based on administration route, the market is segmented into Injectable and Oral. Based on end user, the market is segmented into Poultry Farms, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Bursal Disease Vaccine Market

The global market for Infectious Bursal Disease vaccines is driven by the rapid growth of poultry production, which leads to larger and more intensive flocks. This situation heightens the risk of outbreaks, prompting farmers and poultry integrators to increasingly adopt vaccination strategies. As producers emphasize animal health to enhance both productivity and product quality, the demand for effective immunization rises, urging manufacturers to broaden their supply and innovate customized vaccine formulations. This synergy between increasing production demands and preventive health measures not only solidifies vaccination as a standard farming practice but also promotes investments in distribution networks and educational initiatives, thereby bolstering market expansion.

Restraints in the Global Infectious Bursal Disease Vaccine Market

The Global Infectious Bursal Disease Vaccine market faces significant limitations due to the necessity for strict temperature-controlled storage and handling. This requirement complicates distribution, particularly in remote or resource-limited areas, and increases logistical challenges. The reliance on a reliable cold chain infrastructure places greater operational demands on suppliers, potentially discouraging smallholder producers from implementing vaccination practices due to concerns about convenience and the risk of product spoilage. These distribution barriers hinder market growth by restricting geographic access, complicating supply chain management, and making it difficult for manufacturers to ensure consistent adoption across various farming systems without considerable investments in transportation and storage solutions.

Market Trends of the Global Infectious Bursal Disease Vaccine Market

The Global Infectious Bursal Disease Vaccine market is experiencing a notable shift towards recombinant and novel vaccine platforms, which are becoming central to industry innovation. Manufacturers are focusing on these advanced technologies due to their enhanced safety profiles, customized immune responses, and efficient production workflows. These platforms enable the development of antigen-specific formulations and facilitate integration with disease surveillance strategies, making them increasingly versatile in addressing the evolving challenges posed by viral strains. Consequently, there's a rising investment in scalable manufacturing systems and collaborations between biotech and animal health companies, driven by the growing demand for vaccines that ensure consistent efficacy across diverse poultry populations while aligning with modern production practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis

Global Infectious Bursal Disease Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Live Attenuated Vaccine
  • Single Strain
  • Multivalent
• Inactivated Vaccine
  • Oil-based
  • Water-based

Global Infectious Bursal Disease Vaccine Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Injectable
  • Intramuscular
  • Subcutaneous
• Oral
  • Liquid Formulation
  • Tablet Formulation

Global Infectious Bursal Disease Vaccine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Poultry Farms
  • Commercial Farms
  • Backyard Farms
• Research Institutions
  • Veterinary Research
  • Agricultural Research
• Others

Global Infectious Bursal Disease Vaccine Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Administration Route, End User)
  • US
  • Canada
• Europe (Vaccine Type, Administration Route, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Administration Route, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Administration Route, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Administration Route, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegelec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioveta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axiota Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyGentec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liaoning Hile Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinsha River Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chengdu Tiantai Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sihuan Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations